retatrutide clinical trial results safety ⭐️topline from TRIUMPH-1, a Phase 3 evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” Phase III retatrutide study demonstrates

Role of central serotonin and melanocortin systems in the control of energy balance

Today, on World Eating Disorders Action Day, I'm proud to announce my first book, Hijacked: Anorexia Nervosa in the Age of GLP-1 Medications

Compound Tirzepatide contains the same primary ingredient as its name-brand, FDA approved counterparts Mounjaro and Zepbound

157 In the mitochondrial pathway, disruption of the outer mitochondrial membrane integrity can lead to mitochondrial outer membrane permeabilization (MOMP)

Demirdas et al

Merck discontinued -amino acid-containing molecules due to a lack of selectivity and focused instead on selective amino acid piperazine derivatives, which led to the development of sitagliptin, a compound containing piperazine and triazolopiperazine